The Patient Partnership Index 2020 is a ground-breaking initiative from leading industry publication PharmaTimes magazine and specialist health communications agency OVID Health.

Launched in May 2020, the Index offers pharmaceutical and biotech companies an opportunity to showcase, benchmark and evaluate the quality of their communications and advocacy with patient groups. The aim is to celebrate as many companies that meet the mark, so we can raise the bar across the industry. There are no costs involved – entering the Index is completely free for everyone.

The Index will evaluate the highest standards, based on best practice, of partnerships in communications and advocacy between pharmaceutical, biotech and patient communities.

Companies are offered the opportunity to submit entries to the Index. In return, they will be recognised amongst their industry peers and patient organisations, as well as receive an exclusive insights report from OVID Health. Entries for the 2020 Index are now closed, but you can pre-register for 2021.

“Having a Patient Partnership Index, developed with patient groups and judged independently, can keep us moving forwards, sharing best practice and providing a valuable steer on what works best”

Ben Osborn, Pfizer UK country manager

The final results have been announced (check out our news page for the details) and all entrants will have the opportunity to profile their involvement with the Index through their own external and internal channels.

“We work hard to build trusted, transparent and lasting relationships with patient organisations, no matter how big or small, to help us understand what matters most to patients and their families……we value platforms such as the Patient Partnership Index which enable us to share our initiatives and learn of other important programmes helping to meet the needs of UK patients.”

Gaetan leblay, managing Director of janssen UK & Ireland